JabWatch journal

Semaglutide (Wegovy) approved to treat form of liver disease

Source published 3 July 2026 · JabWatch published 13 August 2026 · Last updated 23 August 2026

The semaglutide injection has been approved to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced liver fibrosis.

Original source

This JabWatch summary links to the original report: GOV.UK / MHRA.

JabWatch provides consumer price information, not medical advice. Check the original source and a pharmacy's terms for the latest details.